Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

INDA vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, INDA returned −14.2% to XBI's +41.2%, and XBI charges 0.35% to INDA's 0.61%.

askIQ about this page

askIQ about INDA and XBI

Net assets on Oct 27, 2026: $5.8bn for iShares MSCI India ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

At a glance
−14.2%
INDA total return, 1 year
+41.2%
XBI total return, 1 year
0.61%
INDA expense ratio
0.35%
XBI expense ratio

Pair scorecard

XBI costs 0.26 points a year less; their one-year returns differ by 55.4 points; XBI is 1.8 times larger.

INDA vs XBI: Differences, Returns & Fees
MeasureINDAXBI
Return
Total return, 1 year−14.2%+41.2%
Drawdown
Below its high20.4%, high on Sep 26, 2024
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksMSCI India IndexBiotech
Cost and size
Expense ratio0.61%0.35%
Net assets, as of Oct 27, 2026$5.8bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
Top ten holdings, share of the fund34.8%18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, INDA and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first INDA XBI
Only in one fund ↓
Only in INDA
HDFC BANK 6.21%
ICICI BANK 5.90%
RELIANCE INDUSTRIES LTD 5.50%
BHARTI AIRTEL LTD 4.44%
INFOSYS 2.83%
AXIS BANK 2.23%
MAHINDRA AND MAHINDRA LTD 1.99%
LARSEN AND TOUBRO LTD 1.97%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

INDA iShares MSCI India ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks the MSCI India Biotech
Total return, 1 year −14.2% +41.2%
Its benchmark over the same days +16.3% (EEM) not measured
Gap to its benchmark −30.5 pts vs EEM not measured
Expense ratio 0.61% 0.35%
Already in the S&P 500 0.0% 13.2%
Holdings 166 165
Net assets, as of Oct 27, 2026 $5.8bn $10.3bn

INDA and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

INDA and XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
INDA

INDA tracks the MSCI India. Over the year to Oct 28, 2026 it returned −14.2% with distributions reinvested, against +16.3% for its benchmark, the MSCI Emerging Markets Index. The prospectus expense ratio is 0.61% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 166 positions, with the top ten at 34.8%. It sat 20.4% below its high of Sep 26, 2024 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are INDA and XBI in the same category?
INDA is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, INDA or XBI?
In the year to Oct 28, 2026, with distributions reinvested, INDA returned −14.2% and XBI +41.2%.
Which is cheaper, INDA or XBI?
XBI is cheaper, by 0.26 percentage points a year. That is about $26 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do INDA and XBI overlap with the S&P 500?
By their latest filed holdings, 0% of INDA and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, INDA against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/inda-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.